APGE

Apogee Therapeutics (APGE)

About Apogee Therapeutics (APGE)

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Details

Daily high

$78.74

Daily low

$76.76

Price at open

$77.78

52 Week High

$80.99

52 Week Low

$26.20

Market cap

4.7B

Dividend yield

0.00%

Volume

465,151

Avg. volume

972,120

P/E ratio

-18.08

Apogee Therapeutics News